Increased primary care visits tied to lower colorectal cancer incidence

More Primary Care Visits, Less Colorectal Cancer Incidence
More Primary Care Visits, Less Colorectal Cancer Incidence

(HealthDay News) -- Higher utilization of primary care among Medicare beneficiaries reduces colorectal cancer (CRC) incidence and mortality, according to a study published in the Oct. 1 issue of the Annals of Internal Medicine.

Jeanne M. Ferrante, M.D., M.P.H., from Rutgers University in New Brunswick, N.J., and colleagues utilized data from the U.S. Surveillance, Epidemiology, and End Results survey to identify patients aged 67 to 85 years diagnosed with CRC between 1994 and 2005 and matched controls (205,804 participants for CRC incidence; 54,160 for CRC mortality; and 121,070 for all-cause mortality). Primary care visits in the four- to 27-month period before CRC diagnosis were assessed.

The researchers found that persons with five to 10 primary care visits had lower CRC incidence (adjusted odds ratio [aOR], 0.94), mortality (aOR, 0.78), and all-cause mortality (aOR, 0.79), compared to patients with no more than one primary care visits. For patients having late-stage CRC diagnosis, distal lesions, and diagnosis in more recent years when there was greater Medicare screening coverage, the associations were even stronger. Ever having CRC screening and polypectomy reduced the association between primary care utilization with CRC incidence.

"Increasing and promoting access to primary care in the United States for Medicare beneficiaries may help decrease the national burden of CRC," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs